转录因子STAT5通过ROS产生驱动慢性髓系白血病突变和伊马替尼耐药

{"title":"转录因子STAT5通过ROS产生驱动慢性髓系白血病突变和伊马替尼耐药","authors":"E. Grundschober, W. Warsch, V. Sexl","doi":"10.1186/1471-2210-11-S2-A22","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":48846,"journal":{"name":"BMC Pharmacology & Toxicology","volume":"18 1","pages":"A22 - A22"},"PeriodicalIF":2.9000,"publicationDate":"2011-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1471-2210-11-S2-A22","citationCount":"1","resultStr":"{\"title\":\"The transcription factor STAT5 drives mutation and imatinib resistance in chronic myeloid leukemia via ROS production\",\"authors\":\"E. Grundschober, W. Warsch, V. Sexl\",\"doi\":\"10.1186/1471-2210-11-S2-A22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":48846,\"journal\":{\"name\":\"BMC Pharmacology & Toxicology\",\"volume\":\"18 1\",\"pages\":\"A22 - A22\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2011-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1186/1471-2210-11-S2-A22\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Pharmacology & Toxicology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/1471-2210-11-S2-A22\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Pharmacology & Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1471-2210-11-S2-A22","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}